Evicenter
MarkdownMedical informationP&T meetings
Darovasertib (IDE196)

First-line metastatic uveal melanoma, in combination with crizotinib

Also known as LXS196
Manufacturer
IDEAYA Biosciences
Launch
Not announced
Last updated
206 sources

Product information and disease descriptionProduct descriptionProduct informationPharmacology

Pharmacokinetics

7 evidence topics · 4 sources

Darovasertib pharmacokinetics in combination with crizotinib

No evidence found.